Literature DB >> 17083106

Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism.

R Mihai1, F F Palazzo, F V Gleeson, G P Sadler.   

Abstract

BACKGROUND: Minimally invasive parathyroidectomy (MIP) is the preferred operation for patients with primary hyperparathyroidism (HPT) and positive preoperative imaging. This non-randomized case series assessed the long-term results of MIP performed without the use of intraoperative parathyroid hormone (ioPTH) monitoring.
METHODS: The study involved prospective collection of demographic, biochemical and operative details on a consecutive, unselected cohort of 298 patients who underwent surgery for non-familial primary HPT during a 5-year interval. The mean preoperative serum calcium level was 3.00 mmol/l with a mean parathyroid hormone concentration of 25.8 pmol/l. (99m)Tc-labelled sestamibi scanning and neck ultrasonography were performed in 262 patients.
RESULTS: Sestamibi scan showed unilateral uptake in 182 patients and a single parathyroid adenoma was confirmed on ultrasonography in 161 patients. MIP was performed in 150 patients. The mean duration of operation was 25 (range 8-65) min. Four patients needed conversion to conventional neck exploration. There was one postoperative haematoma and three cases of temporary recurrent laryngeal nerve neuropraxia. All but four patients were normocalcaemic after MIP. All the parathyroid tumours removed were adenomas, with a mean weight of 1.3 (range 0.1-17.4) g. No patient developed recurrent HPT after a median follow-up of 16 (range 3-48) months.
CONCLUSION: The outcome of MIP without ioPTH monitoring was comparable to that reported in series that used ioPTH monitoring. Copyright 2006 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17083106     DOI: 10.1002/bjs.5574

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  31 in total

1.  Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism.

Authors:  Preethi Gopinath; Gregory P Sadler; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2010-07-25       Impact factor: 3.445

2.  Significance of biochemical parameters in differentiating uniglandular from multiglandular disease and limiting use of intraoperative parathormone assay.

Authors:  Abhijit Thakur; Frederic Sebag; Eveline Slotema; Giuseppe Ippolito; David Taïeb; Jean François Henry
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

3.  Minimally invasive parathyroidectomy without using intraoperative parathyroid hormone monitoring or gamma probe.

Authors:  Aykut Soyder; Mustafa Ünübol; İmran Kurt Ömürlü; Engin Güney; Serdar Özbaş
Journal:  Ulus Cerrahi Derg       Date:  2015-03-01

Review 4.  Simplified minimally invasive parathyroidectomy: a series of 100 cases and review of the literature.

Authors:  W Wong; F J Foo; M I Lau; A Sarin; P Kiruparan
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

5.  Video-assisted bilateral neck exploration in patients with primary hyperparathyroidism and failed localization studies.

Authors:  Pier F Alesina; Reyaz M Singaporewalla; Martin K Walz
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

6.  Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up?

Authors:  Paola Vincenza Sartori; Alberto Maria Saibene; Ennio Leopaldi; Marco Boniardi; Edoardo Beretta; Samuele Colombo; Emanuela Morenghi; Juliana Pauna; Loredana De Pasquale
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-24       Impact factor: 2.503

7.  Is minimally invasive parathyroidectomy without QPTH monitoring justified?

Authors:  Philipp Riss; Christian Scheuba; Reza Asari; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2009-05-14       Impact factor: 3.445

8.  Contemporary surgical treatment of primary hyperparathyroidism without intraoperative parathyroid hormone measurement.

Authors:  O A Mownah; G Pafitanis; W M Drake; J N Crinnion
Journal:  Ann R Coll Surg Engl       Date:  2015-11       Impact factor: 1.891

9.  Cost-effectiveness of scan-directed parathyroidectomy.

Authors:  Radu Mihai; Mary Weisters; Michael J Stechman; Fergus Gleeson; Greg Sadler
Journal:  Langenbecks Arch Surg       Date:  2008-08-01       Impact factor: 3.445

10.  The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: a cost analysis.

Authors:  Lilah F Morris; Kyle Zanocco; Philip H G Ituarte; Kevin Ro; Quan-Yang Duh; Cord Sturgeon; Michael W Yeh
Journal:  Ann Surg Oncol       Date:  2009-11-03       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.